There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Biologics Quality Control: The Growing Need for Accessible Proteomics

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Emerging Therapies Drive Analytical Advancements

Effective analytics will eliminate failures, deviations, and non-conformances.

 Analyzing Exabytes

Topic

Articles

Brief pharmaceutical news items for January 2008.

Pharma Capsules

Editors' Picks of Pharmaceutical Science & Technology Innovations

In the Spotlight January 2008

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

As FDA implements new drug-safety policies, manufacturers will focus on quality and pricing.

Opportunities for 2008

Historically, the main purpose of laboratory information management systems (LIMS) has been to track and manage samples in the laboratory. LIMS originated nearly 30 years ago as a rudimentary method of automating manual, error-prone processes in the laboratory and, with the growth in adoption of technology, became the de facto benchmark for laboratory control and management.

20th Anniversary Special Feature: The transformation and future trends of laboratory data management

Millipore and Novozymes Form Alliance, Applied Biosystems Names President and CEO, More

Company and People Notes: Millipore and Novozymes Form Alliance, Applied Biosystems Names President and CEO, More

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Merck & Co. initiated a voluntary recall of 11 lots of its Haemophilus influenzae type B vaccine, Pedvaxhib, and two lots of its combination Haemophilus influenzae type B/ hepatitis B vaccine, Comvax.

Merck Issues Voluntary Recall of Two Vaccines

Company and People Notes: West to reduce workforce, Eli Lilly's CEO and chairman to retire, more...

Company and People Notes: West To Reduce Workforce, Eli Lilly's CEO and Chairman To Retire, More

Company and People Notes: Eisai Acquires MGI Pharma, Ceregene Names CEO, More

Company and People Notes: Boehringer Ingelheim Expands Facility, Regulus Therapeutics Names President and CEO, More

Analytics

Biologics Quality Control: The Growing Need for Accessible Proteomics

Emerging Therapies Drive Analytical Advancements

Analyzing Exabytes